HeimHLN • NYSE
add
Haleon PLC - ADR
9,51 $
Eftir lokun(0,50%)-0,048
9,46 $
Lokað: 4. ágú., 17:28:22 GMT-4 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
9,66 $
Dagbil
9,44 $ - 9,54 $
Árabil
8,86 $ - 11,42 $
Markaðsvirði
42,67 ma. USD
Meðalmagn
12,98 m.
V/H-hlutf.
22,86
A/V-hlutfall
1,86%
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (GBP) | jún. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 2,74 ma. | -1,26% |
Rekstrarkostnaður | 1,16 ma. | 0,43% |
Nettótekjur | 403,00 m. | 33,00% |
Hagnaðarhlutfall | 14,71 | 34,71% |
Hagnaður á hvern hlut | — | — |
EBITDA | 696,50 m. | -3,06% |
Virkt skatthlutfall | 24,37% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (GBP) | jún. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 676,00 m. | 27,31% |
Heildareignir | 31,83 ma. | -4,70% |
Heildarskuldir | 15,83 ma. | -5,15% |
Eigið fé alls | 16,00 ma. | — |
Útistandandi hlutabréf | 8,99 ma. | — |
Eiginfjárgengi | 5,46 | — |
Arðsemi eigna | 4,78% | — |
Ávöxtun eigin fjár | 6,20% | — |
Peningaflæði
Breyting á handbæru fé
| (GBP) | jún. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 403,00 m. | 33,00% |
Handbært fé frá rekstri | 513,50 m. | — |
Reiðufé frá fjárfestingum | -38,00 m. | — |
Reiðufé frá fjármögnun | -1,26 ma. | — |
Breyting á handbæru fé | -790,50 m. | — |
Frjálst peningaflæði | 369,81 m. | — |
Um
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
Stofnsett
18. júl. 2022
Vefsvæði
Starfsfólk
24.561
